Numelvi

Authorised

This medicine is authorised for use in the European Union

atinvicitinib

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Numelvi
• Active substance:
  atinvicitinib
• International non-proprietary name (INN) or common name:
  atinvicitinib

Pharmacotherapeutic group

• Dermatologicals
• Agents for dermatitis, excluding corticosteroids

Authorisation details

• EMA product number:
  EMEA/V/C/006480

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Numelvi

Adopted Reference Number: EMA/CVMP/179581/2025